Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-10
2011-05-10
Wang, Shengjun (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S258100, C514S231500, C514S226800, C514S252160, C544S282000, C544S056000, C544S098000
Reexamination Certificate
active
07939537
ABSTRACT:
Pyridopyrimidine carboxamide compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication:wherein R1, R2, R3, R4, R5and R6are defined herein. The compounds are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
REFERENCES:
patent: 6841558 (2005-01-01), Anthony et al.
patent: 6919351 (2005-07-01), Anthony et al.
patent: 6921759 (2005-07-01), Anthony et al.
patent: 7091209 (2006-08-01), Gardelli et al.
patent: 7109186 (2006-09-01), Walker et al.
patent: 7169780 (2007-01-01), Crescenzi et al.
patent: 7211572 (2007-05-01), Miyazaki et al.
patent: 7217713 (2007-05-01), Crescenzi et al.
patent: 7232819 (2007-06-01), Di Francesco et al.
patent: 7279487 (2007-10-01), Egbertson et al.
patent: 2003/0055071 (2003-03-01), Anthony et al.
patent: 2004/0229909 (2004-11-01), Kiyama et al.
patent: 2005/0010048 (2005-01-01), Zhuang et al.
patent: 2005/0130997 (2005-06-01), Avolio et al.
patent: 2006/0046985 (2006-03-01), Crescenzi et al.
patent: 2007/0083045 (2007-04-01), Di Francesco et al.
patent: 2007/0123524 (2007-05-01), Crescenzi et al.
patent: 2007/0161639 (2007-07-01), Jones et al.
patent: 2007/0179196 (2007-08-01), Han et al.
patent: WO 2004/058757 (2004-07-01), None
patent: WO 2005/086700 (2005-09-01), None
patent: WO 2005/118589 (2005-12-01), None
patent: WO 2005/118593 (2005-12-01), None
patent: WO 2006/116764 (2006-11-01), None
Goodman & Gilman's “The PHarmaceutical Basic of Therapeutics,” 9th Edition, 1996, pp. 43-61.
Pearl, L. et al. “A structural model for the retroviral proteases”, Nature, 1987, vol. 329, pp. 351-354.
Power, M. et al. “Nucleotide Sequence of SRV-1, a Type D Simian Acquired Immune Deficiency Syndrome Retrovirus”, Science, 1986, vol. 231, pp. 1567-1572.
Ratner, L. et al. “Complete nucleotide sequence of the AIDS virus, HTLV-III”, Nature, 1985, vol. 313, pp. 277-284.
Tisler, M. et al. “An Improved Synthesis of Dimethyl Diacetoxyfumarate and Its Condensation with Heterocyclic Amines”, OPPI Briefs, 1990, vol. 22, pp. 532-534.
Toh, H. et al. “Close structural resemblance between putative polymerase of a Drosophila transposable genetic element 17.6 and pol gene product of Moloney murine leukaemia virus”, The EMBO Journal, 1985, vol. 4, pp. 1267-1272.
Donghi Monica
Kinzel Olaf
Summa Vincenzo
Heber Sheldon O.
Istituto di Ricerche di Biologia Molecolare P. Angeletti S.p.A.
Walton Kenneth R.
Wang Shengjun
LandOfFree
HIV integrase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HIV integrase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIV integrase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2703627